BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19521325)

  • 1. Pediatric regimens for adult acute lymphoblastic leukemia.
    Stock W
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):244-6. PubMed ID: 19521325
    [No Abstract]   [Full Text] [Related]  

  • 2. [High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol].
    Castell V; Verdaguer A; Ferris J; Piqueras AI; Fernández JM
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():89-91. PubMed ID: 3214045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol].
    Bernacer M; Aracil J; Contra T; Gil C; López J; López-Ibor B; Martín N; Melero C; Valverde F; Vecilla C
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():68-72. PubMed ID: 3214042
    [No Abstract]   [Full Text] [Related]  

  • 4. Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?
    Douer D
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):647-58. PubMed ID: 19041604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and treatment of acute lymphoblastic leukemia.
    Pieters R; Carroll WL
    Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pediatric acute lymphoblastic leukemia.
    Tucci F; Aricò M
    Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
    [No Abstract]   [Full Text] [Related]  

  • 7. Quest for effective agents to combat T-cell acute lymphoblastic leukemia.
    Pui CH
    Eur J Cancer; 2005 Jun; 41(9):1243-5. PubMed ID: 15939259
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreatic and renal involvement in pediatric acute lymphoblastic leukemia/lymphoma.
    Ikawa Y; Saikawa Y; Horisawa T; Kuroda R
    J Clin Oncol; 2007 Feb; 25(4):451-3. PubMed ID: 17264344
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia.
    Tomar S; Bakhshi S; Kabra SK; Arya LS
    Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625
    [No Abstract]   [Full Text] [Related]  

  • 10. New therapeutic strategies in acute lymphoblastic leukemia.
    Jeha S
    Semin Hematol; 2009 Jan; 46(1):76-88. PubMed ID: 19100370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curability of cancer in childhood and adolescence: acute lymphoblastic leukemia.
    Mann G; Gadner H
    Wien Klin Wochenschr; 2002 Feb; 114(4):141-2. PubMed ID: 12060979
    [No Abstract]   [Full Text] [Related]  

  • 12. The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?
    Pinheiro JP; Boos J
    Br J Haematol; 2004 Apr; 125(2):117-27. PubMed ID: 15059133
    [No Abstract]   [Full Text] [Related]  

  • 13. The U.S. trials in adult acute lymphoblastic leukemia.
    Larson RA
    Ann Hematol; 2004; 83 Suppl 1():S127-8. PubMed ID: 15124704
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
    Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
    Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of the laboratory scientist in the diagnosis and treatment of acute lymphoblastic leukemia in children].
    Fournier M; Lambilliotte A
    Ann Biol Clin (Paris); 1998; 56(3):343-7. PubMed ID: 9754267
    [No Abstract]   [Full Text] [Related]  

  • 16. A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia.
    Daenen S; van Imhoff GW; de Wolf JT; Vellenga E; van den Berg-de Ruiter E; Kluin-Nelemans HC
    Br J Haematol; 2007 Jul; 138(2):275-7. PubMed ID: 17593034
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal.
    Hunger SP; Sung L; Howard SC
    Pediatr Blood Cancer; 2009 May; 52(5):559-65. PubMed ID: 19127567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab as therapy for acute lymphoblastic leukemia.
    Thomas DA
    Clin Adv Hematol Oncol; 2010 Mar; 8(3):168-71. PubMed ID: 20400931
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence to oral chemotherapy in childhood acute lymphoblastic leukemia: an evolutionary concept analysis.
    Landier W
    Oncol Nurs Forum; 2011 May; 38(3):343-52. PubMed ID: 21531684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
    Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
    Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.